The modified Merocel (R) pope ear wick in severe acute otitis externa management

Department of Otorhinolaryngology, Head & Neck Surgery, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK. E-mail: .
Clinical otolaryngology: official journal of ENT-UK; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery (Impact Factor: 2.11). 02/2012; 37(1):85-6. DOI: 10.1111/j.1749-4486.2012.02435.x
Source: PubMed
183 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Question: In the summer months I see many children with uncomplicated acute otitis externa (AOE). I am aware of the multiple ototopical preparations. Which is the best first-line agent to treat AOE, and is there a role for an oral antibiotic? Answer: There are no specific Canadian guidelines for the management of AOE. However, current American guidelines promote initial ototopical therapy without systemic antibiotics for uncomplicated AOE; suggest there is little difference between the various ototopical preparations; and recommend the choice of treatment be based on the specific clinical situation. In practice, this often results in prescribing an antibiotic-steroid formulation for 7 to 10 days. This ototopical treatment option is supported by a recent Cochrane review that has documented the superiority of an antibiotic-steroid combination when compared with placebo or acetic acid in providing clinical resolution of AOE.
    Canadian family physician Medecin de famille canadien 11/2012; 58(11):1222-1224. · 1.34 Impact Factor